Literature DB >> 5086216

A clinical and experimental study of platelet function in chronic renal failure.

E P Evans, R A Branch, A L Bloom.   

Abstract

Coagulation and platelet function studies were performed on 24 normal subjects and 29 patients with chronic renal failure due to various causes. Thrombocytopenia was uncommon in the uraemic patients but there was reduced platelet retention in glass bead columns and platelet aggregation with adenosine diphosphate (ADP) and thrombin was slower and less complete than normal. The rate of platelet disaggregation in uraemic patients was significantly reduced. The abnormalities tended to be more severe in more uraemic subjects. In normal subjects no inter-relationships were observed between the various measurements of platelet activity. In patients there were significant interrelationships between the measurements of platelet aggregation with ADP and thrombin and between the measurements of aggregation and retention in glass bead columns. It is suggested that if a common pathway is involved in these reactions it is adversely affected in uraemia. Plasma coagulation defects were uncommon and present in only five of the uraemic subjects. Impaired prothrombin consumption apparently due to defective platelet function was present in half the patients but was not detected by a kaolin activation method. Although platelet coagulation function was activated during ADP aggregation and disaggregation in normal and uraemic subjects, it did not correlate in the latter with impairment of aggregation. It is suggested that aggregation and activation of platelet coagulant activity are not necessarily related aspects of platelet function. An effect of uraemic plasma on normal platelets was demonstrated by mixing experiments consistent with a humoral cause for the uraemic platelet defects.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5086216      PMCID: PMC477502          DOI: 10.1136/jcp.25.9.745

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  The bleeding disorder of uraemia. A qualitative platelet defect.

Authors:  P A Castaldi; M C Rozenberg; J H Stewart
Journal:  Lancet       Date:  1966-07-09       Impact factor: 79.321

2.  Platelet function and von Willebrand's disease.

Authors:  A Holdrinet; M Ewals; C Haanen
Journal:  Lancet       Date:  1968-05-25       Impact factor: 79.321

3.  [Various comments on thrombocytopathy acquired in uremic diseases].

Authors:  S I de Vries; J W ten Cate; M E den Hartog-Veerman; M M van Dooren
Journal:  Schweiz Med Wochenschr       Date:  1968-10-19

4.  Adhesiveness of blood platelets in uremia.

Authors:  E W Salzman; L L Neri
Journal:  Thromb Diath Haemorrh       Date:  1966-01-31

5.  The rate of platelet aggregation in haemorrhagic disease and thrombosis.

Authors:  M C Rozenberg; B G Firkin
Journal:  Scand J Haematol       Date:  1966

6.  Defective ADP-induced platelet factor 3 activation in uremia.

Authors:  H I Horowitz; B D Cohen; P Martinez; M F Papayoanou
Journal:  Blood       Date:  1967-09       Impact factor: 22.113

7.  Possible mechanism of aggregation of blood platelets by adenosine diphosphate.

Authors:  E W Salzman; D A Chambers; L L Neri
Journal:  Nature       Date:  1966-04-09       Impact factor: 49.962

8.  Platelet aggregation and the availability of platelet factor 3.

Authors:  R M Hardisty; R A Hutton
Journal:  Br J Haematol       Date:  1966-11       Impact factor: 6.998

9.  Haemostatic mechanism in uraemia.

Authors:  R A Hutton; M J O'Shea
Journal:  J Clin Pathol       Date:  1968-05       Impact factor: 3.411

10.  Adenosine diphosphate (ADP) breakdown in human plasma with reference to platelet aggregation and uraemia.

Authors:  I E Gan; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1968-07-31
View more
  9 in total

1.  High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients.

Authors:  Miklos Z Molnar; Elani Streja; Csaba P Kovesdy; Matthew J Budoff; Allen R Nissenson; Mahesh Krishnan; Stefan D Anker; Keith C Norris; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2011-08-03       Impact factor: 7.045

2.  Bleeding in renal failure: a possible cause.

Authors:  M Kazatchkine; Y Sultan; J P Caen; J Bariety
Journal:  Br Med J       Date:  1976-09-11

3.  Role of endothelium-derived nitric oxide in the bleeding tendency of uremia.

Authors:  G Remuzzi; N Perico; C Zoja; D Corna; D Macconi; G Viganò
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 4.  Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy.

Authors:  Constance C F M J Baaten; Jonas R Schröer; Jürgen Floege; Nikolaus Marx; Joachim Jankowski; Martin Berger; Heidi Noels
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-08       Impact factor: 8.237

5.  The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation.

Authors:  S Túri; C Bereczki; C Torday; Z Havass; M Németh
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

6.  Platelet Function in CKD: A Systematic Review and Meta-Analysis.

Authors:  Constance C F M J Baaten; Marieke Sternkopf; Tobias Henning; Nikolaus Marx; Joachim Jankowski; Heidi Noels
Journal:  J Am Soc Nephrol       Date:  2021-05-03       Impact factor: 14.978

7.  Spontaneous renal hemorrhage in hemodialysis patients.

Authors:  Takashi Kawahara; Kimiko Kawahara; Hiroki Ito; Satoshi Yamaguchi; Hiroshi Mitsuhashi; Kazuhide Makiyama; Hiroji Uemura; Masashi Sakai; Yoshinobu Kubota
Journal:  Case Rep Nephrol Urol       Date:  2011-08-08

8.  Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients.

Authors:  Ksenija Stach; Susanne Karb; Ibrahim Akin; Martin Borggrefe; Bernhard Krämer; Thorsten Kälsch; Anna-Isabelle Kälsch
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711

9.  Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease.

Authors:  Alyaa Abdelmaguid; Lara N Roberts; Laura Tugores; Jennifer R Joslin; Beverley J Hunt; Kiran Parmar; Danilo Nebres; Salah S Naga; Eman S Khalil; Kate Bramham
Journal:  J Thromb Haemost       Date:  2022-02-03       Impact factor: 16.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.